Informed-money record
VRNA · Verona Pharma plc
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
13
Named actors
13
Disclosed $ (bull / bear)
$0 / $7.1M
Recent disclosures
13 of 13 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2025-08-01 | Director Sinha Vikas | sold | $57K | SEC ↗ |
| 2025-08-01 | Director SHAH MAHENDRA | sold | $47K | SEC ↗ |
| 2025-08-01 | Director Edwards Martin | sold | $142K | SEC ↗ |
| 2025-08-01 | Director EBSWORTH DAVID R | sold | $25K | SEC ↗ |
| 2025-08-01 | President and CEO ZACCARDELLI DAVID | sold | $2.7M | SEC ↗ |
| 2025-08-01 | Director Brady James Aloysius | sold | $11K | SEC ↗ |
| 2025-08-01 | Director Austwick Michael | sold | $148K | SEC ↗ |
| 2025-08-01 | Director ACKERMANN CHRISTINA | sold | $24K | SEC ↗ |
| 2025-08-01 | Chief Medical Officer Rickard Kathleen A. | sold | $767K | SEC ↗ |
| 2025-08-01 | Chief Financial Officer Hahn Mark W | sold | $2.7M | SEC ↗ |
| 2025-08-01 | General Counsel Fisher Andrew | sold | $126K | SEC ↗ |
| 2025-08-01 | Director Deschamps Lisa | sold | $124K | SEC ↗ |
| 2025-08-01 | Director Cunningham Kenneth | sold | $142K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals